Tag: OneSource
OneSource-Hikma partnership secures approval to commercialise generic version of Ozempic in...
Under the exclusive agreement, OneSource will manufacture and supply semaglutide from its state- of-the-art integratedBiologics and Drug-Device Combination facility
OneSource and Xbrane Biopharma enter into strategic biosimilars manufacturing partnership for...
The lead candidate Ximluci (a ranibizumab biosimilar) is granted market authorization approval in Europe (launched in 2023) and is now under the approval process for the US launch
Strides Pharma secures approvals for OneSource, India’s first specialty pharma CDMO
Approval from equity shareholders and secured creditors marks a major milestone in the creation of OneSource
OneSource and BRL announce licensing agreement on advanced biologics delivery technology
Revolutionary HILOPRO® technology to enhance subcutaneous delivery of high-concentration biologics, boosting OneSource’s scientific services
Strides records revenue of Rs 40,555 million in FY24, YoY growth...
The company reports highest ever revenue and EBITDA growth up to 77.6%, declares ₹2.5 per share dividend